<DOC>
	<DOCNO>NCT00889915</DOCNO>
	<brief_summary>This study determine whether two new psychostimulant medication effective , tolerable , acceptable two old medication treat attention deficit hyperactivity disorder .</brief_summary>
	<brief_title>Comparing Effectiveness New Versus Older Treatments Attention Deficit Hyperactivity Disorder ( The NOTA Study )</brief_title>
	<detailed_description>Attention deficit hyperactivity disorder ( ADHD ) characterize impulsiveness , hyperactivity , inattention . It see primarily child adolescent often treat psychostimulant medication . Osmotic-release oral system ( OROS ) methylphenidate , brand name Concerta , mixed amphetamine salt extend release , brand name Adderall XR , psychostimulant medication show efficacy ( therapeutic benefit ) effectiveness ( typically therapeutic benefit practice ) . Two new psychostimulant medications—lisdexamfetamine dimesylate , brand name Vyvanse , methylphenidate transdermal system , brand name Daytrana—have show efficacy test effectiveness , test head-to-head old psychostimulants . This study test effectiveness , tolerability ( lack side effect ) , acceptability ( ease use patient ) two new psychostimulant medication compare two old psychostimulants . Participation study last 6 week , although treatment may continue past end study . At enrollment , participant undergo series baseline evaluation . These include interview assessment ADHD symptom , concurrent psychiatric disorder , medical psychiatric history , family history mental illness , risk protective factor , treatment , treatment expectancy youth parent , vital sign . In consultation doctor , participant allow exclude zero , one , two study medication ; choose exclude new ADHD medication , able participate study . Participants randomly assign one treatment choose include . They receive prescription medication instruction use doctor ; study protocol specify particular treatment regimen . Participants undergo second set evaluation 6 week treatment , treatment end earlier . This include interviews assessment similar administer baseline well evaluation medication side effect .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<mesh_term>Adderall</mesh_term>
	<criteria>Meets DSMIV diagnostic criterion ADHD combine , hyperactive/impulsive , inattentive subtype Outpatient study entry Speaks English Willing randomly assign one study treatment option outline protocol No known significant history cardiovascular disorder , include preexist congenital heart disease , structural heart disease , know clinically significant electrocardiogram ( ECG ) abnormality , clinically significant cardiac disorder Willing initiate study medication ADHD within 7 day study baseline visit May receive stable treatment drug comorbid disorder , define change dose form drug treatment least 2 week prior study enrollment visit May receive psychosocial intervention ADHD comorbid disorder , define change form psychosocial treatment least 4 week prior study enrollment visit Hypersensitivity study medication Inpatient status study entry Currently take another medication ADHD , include another psychostimulant , atomoxetine , bupropion Receiving treatment tricyclic antidepressant study enrollment , exception lowdose imipramine enuresis amitriptyline chronic pain Received treatment monoamine oxidase inhibitor ( MAOI ) within past 30 day Psychostimulant drug dependence , bipolar disorder , schizophrenia Presence psychosis Severe mental retardation Autism Asperger 's syndrome Active suicidal ideation Unable unwilling comply protocol Demonstrates lack benefit , intolerance , contraindication psychostimulant medicine Presence clinically significant medical condition , include hyperthyroidism , epilepsy seizure disorder , condition increase blood pressure heart rate would problematic , glaucoma significant eye disease psychostimulant would problematic , preexist gastrointestinal obstruction gastrointestinal narrowing Pregnant positive result pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Methylphenidate</keyword>
	<keyword>Amphetamine</keyword>
</DOC>